Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
about
Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle DisordersCompetition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary artery.A bioinformatic and computational study of myosin phosphatase subunit diversity.Myosin phosphatase isoforms and related transcripts in the pig coronary circulation and effects of exercise and chronic occlusion.Neural programming of mesenteric and renal arteries.Vascular smooth muscle phenotypic diversity and functionRole of rho kinase in the functional and dysfunctional tonic smooth muscles.TRA2β controls Mypt1 exon 24 splicing in the developmental maturation of mouse mesenteric artery smooth muscleRegulation of basal LC20 phosphorylation by MYPT1 and CPI-17 in murine gastric antrum, gastric fundus, and proximal colon smooth muscles.Tra2β protein is required for tissue-specific splicing of a smooth muscle myosin phosphatase targeting subunit alternative exon.Redox signaling and splicing dependent change in myosin phosphatase underlie early versus late changes in NO vasodilator reserve in a mouse LPS model of sepsis.Altered Expression of Human Smooth Muscle Myosin Phosphatase Targeting (MYPT) Isovariants with Pregnancy and Labor.Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase.Differential vasodilation of human placental and myometrial arteries related to myofilament Ca(2+)-desensitization and the expression of Hsp20 but not MYPT1.Tra2beta as a novel mediator of vascular smooth muscle diversification.The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failureSmooth muscle contractile diversity in the control of regional circulations.Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production.Novel contributions of the smoothelin-like 1 protein in vascular smooth muscle contraction and its potential involvement in myogenic tone.MYPT1 protein isoforms are differentially phosphorylated by protein kinase G.MYPT1 isoforms expressed in HEK293T cells are differentially phosphorylated after GTPγS treatment.Altered reactivity of tertiary mesenteric arteries following acute myocardial ischemia.Unique gene program of rat small resistance mesenteric arteries as revealed by deep RNA sequencing.A splice variant of the myosin phosphatase regulatory subunit tunes arterial reactivity and suppresses response to salt loadingROS-mediated downregulation of MYPT1 in smooth muscle cells: a potential mechanism for the aberrant contractility in atherosclerosis.Uterine artery myosin phosphatase isoform switching and increased sensitivity to SNP in a rat L-NAME model of hypertension of pregnancy.Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature.Hypoxic pulmonary vasoconstriction
P2860
Q26753129-24C73FF2-8422-4F27-884E-58F76D0813CFQ28565269-D070272C-6AF6-432A-AC39-698AB7229791Q33428533-56119745-BB05-442C-9A59-64E4C523F62DQ33994665-9C748117-DA63-435A-886E-6214D4EA8ADCQ34001586-ADC2B518-CFCC-4B43-A762-0D1748D54450Q34051651-6AD52840-0B3E-4680-8620-EC789B20CA35Q34062825-1A31B663-FB2B-4203-AF3B-26DE339754AFQ34432730-EA47AA7F-18BA-4B59-851B-DF426637DEBCQ35083933-1C0CA552-5BCD-4BFA-AB6A-378BC4C48339Q35086281-305AE704-B0D6-4E65-B568-4CB32ECCF42CQ35214205-C708DA0F-DDBD-472D-B854-C2710A26C31AQ35956484-51915990-A885-4278-97DF-2D0F51F87E18Q36000019-58A418BE-1D8F-46AC-B1E8-88971A1A146AQ36178519-56E45A64-3CA4-435C-96DB-560FBF003C11Q36977280-C76851D2-85BC-4DDE-98CE-0571F60ABA21Q37272271-42813545-C5D2-4875-90D8-87096702C2B8Q37332178-6909E64D-333F-46FC-BBA8-E038181A26CEQ37361567-0ABBE86C-F4E5-433E-8185-C51F05D1D5D4Q37575852-8A6BB905-72BF-4D17-A62A-011F31E93F8DQ38151237-3821BE9B-686B-41EA-86A0-2895C8EB5948Q38165311-E94B2AD4-D9EC-4A4D-9274-5479D68E0394Q38795387-E6EA7284-68F5-48B7-9C3E-305E0AF57B42Q39304331-84CF3B74-FB1C-4D3B-B2D2-B04EA8B07453Q40301580-EF0B524E-B926-4E6D-86BF-3FE45A996CC2Q41891029-7E38332A-9A99-4376-B553-730F8DEF7677Q42109947-8B25DC38-0E24-40FE-BD5E-074E47F04598Q45113305-2379C033-173E-4863-833C-9A4DF1968D43Q46840707-200EC971-85C4-4E62-BF06-D13E2B1F551BQ51869172-EA03E2EE-49DE-40CE-A96E-5228126CCB99Q53881337-D174ADAC-6BA3-4758-86BA-C20988D52F20Q57099542-D30FE3BC-74CA-471F-85A2-B19635DC4DA9
P2860
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@en
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@nl
type
label
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@en
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@nl
prefLabel
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@en
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@nl
P2093
P2860
P1476
Dynamic changes in expression of myosin phosphatase in a model of portal hypertension.
@en
P2093
Hai-Ying Zhang
Joseph N Benoit
Michael C Payne
Mitsuo Ikebe
Steven A Fisher
Yasuhiko Koga
Yuichi Shirasawa
P2860
P304
P356
10.1152/AJPHEART.00696.2003
P577
2004-01-02T00:00:00Z